familial atrial fibrillation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
157
|
1
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Papilloma, Squamous Cell
|
disease |
Neoplasms
|
Neoplastic Process
|
16
|
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Hereditary Diffuse Gastric Cancer
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
312
|
119
|
0.300 |
None |
1.000 |
1 |
|
2004 |
2004 |
Nodular glomerulosclerosis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
59
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
HIV Coinfection
|
disease |
Infections; Immune System Diseases
|
Disease or Syndrome
|
129
|
3
|
0.300 |
None |
1.000 |
1 |
|
2003 |
2003 |
Papillomatosis
|
disease |
Neoplasms
|
Neoplastic Process
|
18
|
|
0.300 |
None |
1.000 |
1 |
|
2002 |
2002 |
Hypertrophy
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
18
|
|
0.300 |
None |
1.000 |
1 |
|
2016 |
2016 |
Kidney Diseases
|
group |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
1180
|
140
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Malignant mesothelioma
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
420
|
12
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Persistent atrial fibrillation
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Pathologic Function
|
156
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Thyroid Neoplasm
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1164
|
135
|
0.260 |
None |
1.000 |
7 |
|
1996 |
2014 |
Lupus Erythematosus, Systemic
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
1883
|
1172
|
0.240 |
None |
1.000 |
7 |
1
|
1999 |
2019 |
Hepatoblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
452
|
22
|
0.220 |
None |
1.000 |
3 |
|
1995 |
2004 |
Hyperoxia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
50
|
|
0.220 |
None |
1.000 |
3 |
|
2004 |
2007 |
Malignant neoplasm of liver
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1649
|
88
|
0.210 |
None |
1.000 |
2 |
|
2004 |
2018 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.200 |
None |
0.984 |
61 |
5
|
1994 |
2019 |
Polycystic Kidney Diseases
|
group |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
276
|
54
|
0.200 |
None |
1.000 |
1 |
|
2007 |
2007 |
Sepsis
|
disease |
Pathological Conditions, Signs and Symptoms; Infections
|
Disease or Syndrome
|
1453
|
144
|
0.200 |
None |
1.000 |
1 |
|
1999 |
1999 |
Diabetes Mellitus, Experimental
|
disease |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Experimental Model of Disease
|
522
|
|
0.200 |
None |
1.000 |
1 |
|
2015 |
2015 |
Liver Neoplasms, Experimental
|
phenotype |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
152
|
|
0.200 |
None |
1.000 |
1 |
|
1996 |
1996 |
Lipoid nephrosis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
50
|
3
|
0.200 |
None |
1.000 |
1 |
|
2014 |
2014 |
Hepatoblastoma Caused By Somatic Mutation
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
106
|
|
0.200 |
None |
1.000 |
1 |
|
2004 |
2004 |
Hypovolemia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Finding
|
37
|
3
|
0.200 |
None |
1.000 |
1 |
|
1999 |
1999 |
Hyperplasia
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Pathologic Function
|
131
|
|
0.200 |
None |
1.000 |
1 |
|
2014 |
2014 |